Medically Reviewed by Dr. Sunita Tandulwadkar | Written by ALIV

PRP, Exosome & Regenerative Specialty Therapies | ALIV

Platelet-rich plasma, exosomes, ovarian rejuvenation — these words appear in increasing numbers of conversations among patients in Pune and Mumbai who have done their research, spoken to specialists, and arrived at the question: "Is this real, does it work for my situation, and is the clinic I'm considering doing it properly?" These are exactly the right questions. And at ALIV Regenerative Wellness, we are committed to answering them with precision — not marketing.

Dr. Sunita Tandulwadkar, ALIV's founder, is one of India's most distinguished specialists in reproductive medicine and regenerative gynaecology. ALIV holds the unique distinction of being involved in some of India's earliest and most carefully documented work in autologous regenerative approaches for fertility and systemic conditions. What we offer in specialty therapies is built on that foundation — and it is offered with the same clinical rigour as all of ALIV's work.

Platelet-Rich Plasma (PRP): What It Is and What It Genuinely Does

PRP (platelet-rich plasma) is derived from your own blood. A sample is drawn, centrifuged to concentrate the platelet fraction, and the resulting platelet-rich preparation is injected or applied at a specific tissue site. Platelets contain growth factors — PDGF, TGF-beta, VEGF, IGF — that play a documented role in tissue repair and regeneration. This is not theoretical: platelets are what your body naturally deploys when a wound needs to heal.

The clinical application of concentrated PRP is an extension of that biology. Whether it works in a specific therapeutic context depends on: the quality of the preparation (centrifugation speed, platelet concentration, activation method), the specific tissue being treated, the condition stage, and the patient's overall health. Read our comparison of ACT and PRP to understand where each is most appropriately applied: ACT vs PRP/PRF — when each makes sense.

PRP for Hair Loss: Exosome Hair Regeneration — Who Is a Fit

Hair loss is one of the most searched regenerative medicine applications in India — and one of the most over-promised. Here is the honest clinical picture.

PRP for androgenetic alopecia (pattern hair loss) has a reasonable evidence base — a 2019 systematic review in the Journal of the American Academy of Dermatology concluded that PRP injections produced statistically significant improvements in hair count and hair shaft diameter in multiple randomised trials, particularly in the earlier stages of hair loss. It is not effective for hair loss driven by active scarring, severe nutritional deficiency that has not been addressed, or very advanced loss where follicles are no longer present.

Exosome hair regeneration is a newer approach — using cell-secreted exosomes (nano-sized vesicles containing signalling molecules) rather than whole cells or platelet concentrations. The early evidence is promising, particularly for patients who have not responded adequately to PRP. Read our detailed guide: exosome hair regeneration — who is a fit, who is not. For those whose hair loss is driven by ferritin deficiency, thyroid dysfunction, or PCOS — which is common in Indian women — addressing the nutritional root cause is essential before or alongside any regenerative approach. See our hair fall and fatigue guide.

Ovarian Rejuvenation: What Is Realistic

Ovarian rejuvenation using autologous approaches is one of the most exciting and contested frontiers in reproductive medicine. The clinical rationale: depleted or aged ovarian tissue may respond to the paracrine signals released by autologous cellular preparations — potentially improving ovarian reserve (AMH levels), follicle quality, and the likelihood of natural conception or improved IVF outcomes.

Dr. Sunita Tandulwadkar has been at the forefront of this work in India, with documented cases of AMH improvement and successful conception in appropriately selected patients following ovarian rejuvenation protocols. This is not a cure for premature ovarian insufficiency, and it is not appropriate for all patients — the eligibility criteria are specific, and the expectations must be explicitly discussed and documented before any procedure begins. Read: PRP ovarian rejuvenation — realistic expectations. For women with PCOS seeking fertility support, see our PCOS and fertility planning guide.

PRP for Athletes: Recovery Without Overclaiming

For athletes dealing with tendon injuries, chronic soft tissue problems, or seeking to support recovery in a natural, non-pharmacological way, PRP is among the best-evidenced regenerative options. The evidence for PRP in lateral epicondylitis (tennis elbow), rotator cuff tendinopathy, and Achilles tendon injury is reasonably strong. For general "performance enhancement" without a specific tissue target, the evidence is significantly thinner. Read: PRP for athletes — recovery vs overclaiming. This connects into the ACT cluster article on ACT for sports recovery.

P-Shot and Sexual Health: Clinical Language, Clinical Standards

Erectile dysfunction (ED) affects a significant and underreported proportion of Indian men — estimates suggest 40% of men over 40 have some degree of ED, with the figure rising with age, metabolic health, and cardiovascular risk. The P-Shot (Priapus Shot) — a PRP-based injection — is one of several regenerative options in the ED management landscape. The evidence is early-stage but promising for specific vascular and tissue-related causes of ED.

At ALIV, the P-Shot is discussed in the clinical context of a full ED assessment — which includes vascular evaluation, hormonal panel, and psychological assessment, because ED is rarely a single-cause problem. The P-Shot at ALIV is positioned within a broader ED management roadmap, not as a standalone procedure. Read our guide: ED options roadmap — where PRP/P-Shot fits.

PRP for Diabetic Foot: Why Wound Care Still Matters

Diabetic foot ulcers are a significant clinical problem — responsible for the majority of non-traumatic lower limb amputations in India. PRP for wound healing in diabetic foot ulcers has among the strongest evidence in the PRP literature: a 2020 systematic review in Wound Repair and Regeneration found significantly higher healing rates and reduced time to closure compared to standard wound care alone.

This is an application where PRP adds meaningful value — but within a comprehensive wound care programme that includes vascular assessment, infection management, offloading, and diabetes optimisation. It is not a substitute for these elements. Read: PRP for diabetic foot — why wound care still matters. This connects to the ACT pillar for patients considering cellular approaches for diabetic complications.

Frequently Asked Questions

Is PRP from my own blood safe?

Yes — because PRP is derived entirely from your own blood, the risks of immune reaction or blood-borne disease transmission are essentially eliminated. The procedural risks (pain, bruising, minor infection at injection site) are managed with standard clinical precautions. Processing quality matters significantly — poorly processed PRP is less effective and potentially more irritating to tissue.

How is exosome therapy different from PRP?

PRP contains concentrated platelets (and their associated growth factors). Exosome therapy uses cell-secreted nano-vesicles containing signalling molecules, genetic material (microRNAs), and growth factors — with potentially more targeted regenerative signalling than whole platelets. Exosome therapy is a newer technology with a smaller but growing evidence base. For hair regeneration specifically, it may offer advantages over PRP for some patients.

Does ovarian rejuvenation work for everyone?

No. Ovarian rejuvenation is a complex, highly specialised procedure appropriate for carefully selected patients — typically those with diminished ovarian reserve (low AMH) who have had a thorough fertility workup and have realistic outcome expectations. It is not appropriate for all causes of infertility and requires explicit, documented consent. Contact ALIV for a detailed eligibility consultation.

How many PRP sessions are needed for hair loss?

For androgenetic alopecia, most clinical protocols involve three sessions approximately one month apart, followed by maintenance sessions every three to six months. Response is assessed at three months after the initial series. Patients with more advanced loss may require a longer or more intensive initial series. Results vary by individual.

Can I combine PRP with other ALIV therapies?

Yes — in many cases, combination approaches produce better outcomes than any single intervention alone. For hair loss, PRP or exosome therapy combined with nutritional correction (ferritin, thyroid, B12) addresses both the regenerative stimulus and the nutritional substrate. For ED, the P-Shot within a broader programme including NAD+ therapy for vascular and mitochondrial support is a clinically rational combination. Your ALIV doctor will guide the right combination for your situation.

Specialty regenerative therapies — done properly, with honest expectations.

At ALIV's Pune and Mumbai clinics, every specialty therapy begins with a proper clinical assessment and a documented consent conversation about realistic outcomes. Dr. Tandulwadkar's team has been doing this since 2015 — with the clinical depth that comes from genuine experience. Visit alivtherapy.in to schedule a consultation.

Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.